PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
11-Jul-2024 Oracle Advances Safety Case Management for Life Science Organizations Oracle Life Sciences
11-Jul-2024 Type 2 diabetes now one of the top five most studied diseases globally, finds new Phesi analysis Phesi
11-Jul-2024 Priory signs a new five-year agreement with Ashtons Ashtons
11-Jul-2024 London’s EuroEyes laser eye clinic recognised as leader in cataract correction LEC London
11-Jul-2024 New Report from Elsevier Reveals Corporate Researchers Ready to Embrace AI but Remain Concerned About Misinformation and Inaccuracy Elsevier
11-Jul-2024 New data shows UK life sciences failing to reach its potential Association of the British Pharmaceutical Industry (ABPI)
09-Jul-2024 Novel treatment improves embryo implantation and live birth rates in infertile women undergoing IVF and ICSI OXOLIFE
09-Jul-2024 Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones Curve Therapeutics
09-Jul-2024 GenesisCare UK Strengthens Board with Appointment of Two Non-Executive Directors GenesisCare UK
09-Jul-2024 Professor Edith Heard appointed new Director and Chief Executive of the Francis Crick Institute The Francis Crick Institute
09-Jul-2024 Microbiotica to Present Positive Update on Manufacturing Progress of its Live Biotherapeutic Products for Forthcoming Melanoma and Ulcerative Colitis Clinical Studies Microbiotica
09-Jul-2024 Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes Roche
09-Jul-2024 iOnctura announces expansion of roginolisib clinical trial program to NSCLC iOnctura
09-Jul-2024 MIG Capital co-leads €63 million Series A round for autoimmune biotech SciRhom MIG Capital
09-Jul-2024 ABPI responds to Wes Streeting’s commitment to boosting the economy through the life sciences sector Association of the British Pharmaceutical Industry (ABPI)
09-Jul-2024 IMFINZI▼(DURVALUMAB) in combination with chemotherapy APPROVED IN GREAT BRITAIN for the treatment of resectable non-small cell lung cancer AstraZeneca
09-Jul-2024 Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development Myricx Bio
09-Jul-2024 Syncona portfolio company Spur provides update on FLT201 and planned Phase III clinical trial Syncona LimitedSyncona Limited
08-Jul-2024 Spur provides update on FLT201 and planned Phase III clinical trial Syncona Limited
05-Jul-2024 London Medical Laboratory responds to Labour’s election victory London Medical Laboratory